Literature DB >> 10327200

Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion.

T Hayashi1, H Warita, K Abe, Y Itoyama.   

Abstract

Cyclin-dependent kinase 5 (cdk5) is a homologue of cell division cycle 2 (cdc2)-like protein kinase. It is mainly expressed in neurons, and supposed to be involved in the dynamic change of neurocytoskeleton structure seen in the brain after ischemia. In the present study, we investigated immunoreactivity for cdk5 and its critical regulatory subunit p35 in rat brain after 90 min of middle cerebral artery (MCA) occlusion. In the control brain, immunoreactive cdk5 was present in some neurons, while p35 was evident in almost all neurons. At 1 h after blood flow restoration, both of them were remarkably increased in the MCA territory. At 3 h, both immunoreactivities were decreased in the ischemic core region, while they became stronger in neurons at the boundary zone of the MCA territory, which decreased thereafter. These results might suggest that increased cdk5 activity in the brain after ischemia caused depolymerization of neurocytoskeletons, which resulted in neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327200     DOI: 10.1016/s0304-3940(99)00201-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Axotomy-Induced Changes of the Protein Profile in the Crayfish Ventral Cord Ganglia.

Authors:  Svetlana Demyanenko; Valentina Dzreyan; Anatoly Uzdensky
Journal:  J Mol Neurosci       Date:  2019-05-07       Impact factor: 3.444

2.  Overexpression of Cdk5 or non-phosphorylatable retinoblastoma protein protects septal neurons from oxygen-glucose deprivation.

Authors:  Kiran S Panickar; Doris Nonner; Michael G White; John N Barrett
Journal:  Neurochem Res       Date:  2008-03-20       Impact factor: 3.996

Review 3.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

4.  Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.

Authors:  Bogachan Sahin; Ammar H Hawasli; Robert W Greene; Jeffery D Molkentin; James A Bibb
Journal:  Eur J Pharmacol       Date:  2008-01-10       Impact factor: 4.432

5.  Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Rui Zhang; Cui Liu; Yaqing Ji; Lei Teng; Yunliang Guo
Journal:  J Mol Neurosci       Date:  2018-09-11       Impact factor: 3.444

6.  TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke.

Authors:  Ya-Bin Ji; Pei-Pei Zhuang; Zhong Ji; Yong-Ming Wu; Yong Gu; Xiao-Ya Gao; Su-Yue Pan; Ya-Fang Hu
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

7.  Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke.

Authors:  Qing-Zhang Tuo; Zhen-Yu Liuyang; Peng Lei; Xiong Yan; Yang-Ping Shentu; Jia-Wei Liang; Huan Zhou; Lei Pei; Yan Xiong; Tong-Yao Hou; Xin-Wen Zhou; Qun Wang; Jian-Zhi Wang; Xiao-Chuan Wang; Rong Liu
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

Review 8.  Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.

Authors:  Lucas Le Roy; Anne Letondor; Cloé Le Roux; Ahmed Amara; Serge Timsit
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

9.  Hypoxia with inflammation and reperfusion alters membrane resistance by dynamically regulating voltage-gated potassium channels in hippocampal CA1 neurons.

Authors:  Yoon-Sil Yang; Joon Ho Choi; Jong-Cheol Rah
Journal:  Mol Brain       Date:  2021-09-23       Impact factor: 4.041

10.  Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.

Authors:  Alessandra Bosutti; Jie Qi; Roberta Pennucci; David Bolton; Sabine Matou; Kamela Ali; Li-Huei Tsai; Jerzy Krupinski; Eugene B Petcu; Joan Montaner; Raid Al Baradie; Francesca Caccuri; Arnaldo Caruso; Giulio Alessandri; Shant Kumar; Cristina Rodriguez; Jose Martinez-Gonzalez; Mark Slevin
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.